Cargando…

Evaluation of SARS-CoV-2 vaccination in pregnant and breastfeeding women

OBJECTIVES: We aimed to assess the safety experience of women vaccinated with vaccines against SARS-CoV-2 during breastfeeding or pregnancy. METHODS: Via an online questionnaire, we have inquired about the safety experience of 2192 pregnant or breastfeeding women vaccinated against SARS-CoV-2, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terezia, Harvanova, Zuzana, Kobliskova, Petr, Novak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Coronavirus (COVID-19) Collection
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265926/ https://www.ncbi.nlm.nih.gov/pubmed/37363194 http://dx.doi.org/10.1016/j.ijregi.2023.06.002

Ejemplares similares

Impact of SARS-CoV-2 vaccination in healthcare workers in a network of clinics in Latin America
por: Zarabanda, David, et al.
Publicado: (2022)

Prevalence of SARS-CoV-2 infection and SARS-CoV-2-specific antibody detection among healthcare workers and hospital staff of a university hospital in Colombia
por: Caballero, Nohemí, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021
por: Laxmaiah, Avula, et al.
Publicado: (2021)

Confounding role of comorbidities and COVID-19 vaccination uptake in clinical utility of hematological biomarkers in Cameroonian patients infected with SARS-CoV-2
por: Moguem Soubgui, Arlette Flore, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infection
por: Bhuiyan, Taufiqur Rahman, et al.
Publicado: (2022)

The impact of earlier reopening to travel in the Western Pacific on SARS-CoV-2 transmission
por: Jin, Shihui, et al.
Publicado: (2022)

Dynamics of SARS-CoV-2 variants characterized during different COVID-19 waves in Mali
por: Koné, Amadou, et al.
Publicado: (2022)

SARS-CoV-2 viral dynamics of the first 1000 sequences from Vietnam and neighbouring ASEAN countries
por: Hoan, Nghiem Xuan, et al.
Publicado: (2022)

Seroprevalence of anti-SARS-CoV-2 antibodies in a population living in Bomassa village, Republic of Congo
por: Lobaloba Ingoba, Line, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a tertiary care hospital in Riyadh, Saudi Arabia
por: Almaghrabi, Reem S., et al.
Publicado: (2021)

SARS-CoV-2 prevalence at eight urban health clinics in Nicaragua: possible implications for the COVID-19 pandemic
por: Huete-Pérez, Jorge A., et al.
Publicado: (2022)

Symptoms in the acute phase of SARS-CoV-2 infection among Danish children aged 0–14 years
por: Berg, Selina Kikkenborg, et al.
Publicado: (2023)

Paediatric healthcare and hospital worker SARS-CoV-2 IgG antibody: A longitudinal cohort study
por: Cappetto, Kaitlin D., et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 IgG antibodies in a healthcare setting during the first pandemic wave in Senegal
por: Ahouidi, Ambroise D., et al.
Publicado: (2021)

Clinical outcomes in individuals hospitalized with SARS-CoV-2 Delta variant (B.1.617.2) who had been vaccinated with Covishield (ChAdOx1) and Covaxin (BBV-152)
por: Munigela, Apoorva, et al.
Publicado: (2022)

Seroprevalence of anti-SARS-CoV-2 IgG antibodies: relationship with COVID-19 diagnosis, symptoms, smoking, and method of transmission
por: Bühler, Kora-Mareen, et al.
Publicado: (2022)

Seroepidemiology and risk factors for SARS-CoV-2 infection among household members of food processing and farm workers in North Carolina
por: Sciaudone, Michael, et al.
Publicado: (2023)

Simple and low-cost nucleic acid extraction methods for detection of SARS-CoV2 in self-collected saliva and dry oral swabs
por: Shwetha, J.V., et al.
Publicado: (2022)

Seroprevalence of anti-SARS-CoV-2 antibodies in Senegal: a national population-based cross-sectional survey, between October and November 2020
por: Talla, Cheikh, et al.
Publicado: (2022)

Trend of expansion of SARS-CoV-2 infection and COVID-19 burden in Gabon (Central Africa) in mid-2021, based on a serological survey
por: Iroungou, Berthe A., et al.
Publicado: (2022)

Characteristics and outcomes of SARS-CoV-2 positivity in neonates born to mothers with COVID-19 in Klang Valley, Malaysia: a retrospective observational study
por: Lim, Sok Bee, et al.
Publicado: (2022)

Evaluating the strategies to control SARS-CoV-2 Delta variant spread in New Caledonia, a zero-COVID country until September 2021
por: Ochida, Noé, et al.
Publicado: (2023)

Detection of SARS-CoV-2 in Clinical Samples: Target-specific Analysis of Qualitative Reverse Transcription–Polymerase Chain Reaction(RT-PCR) Diagnostic Kits
por: Rangaiah, Ambica, et al.
Publicado: (2021)

Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assays
por: Boler, Michael, et al.
Publicado: (2023)

Effects of hydrometeorological and other factors on SARS-CoV-2 reproduction number in three contiguous countries of tropical Andean South America: a spatiotemporally disaggregated time series analysis
por: Colston, Josh M., et al.
Publicado: (2022)

SARS-CoV-2 B.1.214.1, B.1.214.2 and B.1.620 are predominant lineages between December 2020 and July 2021 in the Republic of Congo
por: Mfoutou Mapanguy, Claujens Chastel, et al.
Publicado: (2022)

High anti-SARS-CoV-2 seroprevalence among unvaccinated mother–child pairs from a rural setting in north-eastern Tanzania during the second wave of COVID-19
por: Msemo, Omari Abdul, et al.
Publicado: (2022)

Second round statewide sentinel-based population survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India, during January-February 2021
por: Padma, M Rajagopal, et al.
Publicado: (2021)

Rates, types, and associated factors of acute adverse effects after the first dose of ChAdOx1 nCoV-19 vaccine administration in Thailand
por: Watcharananan, Sirapat Arthur, et al.
Publicado: (2021)

Adverse events following introduction of the ChAdOx1 nCoV-19 vaccine in Somalia in 2021: findings from a fragile setting and implications for the future
por: Hamayoun, Mohammad, et al.
Publicado: (2022)

What is driving unwillingness to receive the COVID-19 vaccine in adult Bangladeshi after one year of vaccine rollout? Analysis of observational data
por: Ali, Mohammad
Publicado: (2022)

Analyzing Iranian opinions toward COVID-19 vaccination
por: Nezhad, Zahra Bokaee, et al.
Publicado: (2022)

Does ChAdOx1-S and BNT162b2 heterologous prime-boost vaccination trigger higher rates of vaccine-related adverse events?
por: Haji, Alhan, et al.
Publicado: (2023)

COVID-19 vaccine acceptance among healthcare workers in the United Arab Emirates
por: AlKetbi, Latifa Mohammad Baynouna, et al.
Publicado: (2021)

COVID-19 vaccine hesitancy in Ethiopia in 2021: a multicenter cross-sectional study
por: Erega, Besfat Berihun, et al.
Publicado: (2022)

The disproportionate case–fatality ratio of COVID-19 between countries with the highest vaccination rates and the rest of the world
por: Haider, Najmul, et al.
Publicado: (2023)

Primary series COVID-19 vaccine effectiveness among healthcare workers in Albania, February–December 2021
por: Rubin-Smith, Julia E., et al.
Publicado: (2023)

Antibody responses to mRNA versus non-mRNA COVID vaccines among the Mongolian population
por: Sereejav, Enkhbold, et al.
Publicado: (2023)

Adverse events of Oxford/AstraZeneca's COVID-19 vaccine among health care workers of Ayder Comprehensive Specialized Hospital, Tigray, Ethiopia
por: Tequare, Mengistu Hagazi, et al.
Publicado: (2021)

Ten public health strategies to control the Covid-19 pandemic: the Saudi Experience
por: AlFattani, Areej, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qdmbocvmnh3u7br5eqvhad39ni